Amphastar Pharmaceuticals, Inc.
Prognozy (mln)
| Okres |
2024-12-31 |
2025-12-31 |
2026-12-31 |
2027-12-31 |
2028-12-31 |
2029-12-31 |
| Przychód (średnia) |
734.23 |
722.48 |
761.51 |
792.35 |
857.00 |
911.00 |
| Przychód Δ r/r |
0.00% |
-1.60% |
5.40% |
4.05% |
8.16% |
6.30% |
| Przychód (min) |
730.45 |
685.92 |
726.00 |
792.35 |
825.40 |
877.41 |
| Przychód (max) |
737.62 |
749.45 |
803.00 |
792.35 |
886.89 |
942.77 |
| EBITDA (średnia) |
193.69 |
190.59 |
200.89 |
209.02 |
226.08 |
240.32 |
| EBIT (średnia) |
144.38 |
142.07 |
149.75 |
155.81 |
168.53 |
179.14 |
| EBIT % |
19.66% |
19.66% |
19.66% |
19.66% |
19.66% |
19.66% |
| Zysk netto (średni) |
204.18 |
162.92 |
176.74 |
167.03 |
181.68 |
190.01 |
| Zysk netto % |
27.81% |
22.55% |
23.21% |
21.08% |
21.20% |
20.86% |
| EPS (średnia) |
3.87 |
3.13 |
3.52 |
3.76 |
3.49 |
3.65 |
| Liczba analityków (Przychody) |
5 |
4 |
6 |
5 |
1 |
2 |
| Liczba analityków (EPS) |
4 |
5 |
4 |
2 |
1 |
1 |
| symbol |
AMPH |
AMPH |
AMPH |
AMPH |
AMPH |
AMPH |